Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,447Revenue $M596Net Margin (%)9.6Z-Score13.2
Enterprise Value $M3,032EPS $0.8Operating Margin %14.9F-Score6
P/E(ttm))59.4Cash Flow Per Share $1.3Pre-tax Margin (%)15.2Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %0Quick Ratio4.1Cash flow > EarningsN
Price/Sales5.65-y EBITDA Growth Rate %-2.4Current Ratio4.6Lower Leverage y-yY
Price/Cash Flow16.5y-y EBITDA Growth Rate %-34.2ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)6.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M71.3ROI % (ttm)18.6Gross Margin Increase y-yY

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLNWQ Managers 2014-12-31 Reduce-0.1%$23.63 - $32.75
($29.3)
$ 48.3239%Reduce -30.25%906,043
IPXLJoel Greenblatt 2014-12-31 Add0.01%$23.63 - $32.75
($29.4)
$ 48.3239%Add 136.17%79,609
IPXLMario Gabelli 2014-12-31 Buy $23.63 - $32.75
($29.3)
$ 48.3239%New holding6,775
IPXLNWQ Managers 2014-09-30 Add0.08%$22.77 - $30.68
($25.55)
$ 48.3247%Add 31.90%1,298,995
IPXLJoel Greenblatt 2014-09-30 Buy 0.01%$22.77 - $30.68
($25.55)
$ 48.3247%New holding33,709
IPXLNWQ Managers 2014-06-30 Buy 0.3%$23.6 - $30.68
($26.93)
$ 48.3244%New holding984,841
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 48.3257%Sold Out0
IPXLJoel Greenblatt 2011-12-31 Reduce-0.47%$16.53 - $20.75
($18.65)
$ 48.3261%Reduce -88.51%21,057
IPXLJoel Greenblatt 2011-09-30 Reduce-0.38%$15.26 - $21.56
($19.54)
$ 48.3260%Reduce -40.22%183,187
IPXLJoel Greenblatt 2011-06-30 Add0.76%$20.21 - $28.73
($25.28)
$ 48.3248%Add 446.09%306,452
IPXLGeorge Soros 2011-06-30 Sold Out $20.21 - $28.73
($25.28)
$ 48.3248%Sold Out0
IPXLJoel Greenblatt 2011-03-31 Reduce-1.55%$20.11 - $25.52
($22.84)
$ 48.3253%Reduce -78.32%56,118
IPXLGeorge Soros 2011-03-31 Reduce$20.11 - $25.52
($22.84)
$ 48.3253%Reduce -41.13%13,600
IPXLJoel Greenblatt 2010-12-31 Buy 1.7%$17.91 - $21.86
($19.9)
$ 48.3259%New holding258,801
IPXLGeorge Soros 2010-12-31 Buy 0.01%$17.91 - $21.86
($19.9)
$ 48.3259%New holding23,100
IPXLGeorge Soros 2010-06-30 Sold Out $16.66 - $21.62
($19.29)
$ 48.3260%Sold Out0
IPXLGeorge Soros 2010-03-31 Buy $13 - $18.05
($14.93)
$ 48.3269%New holding17,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HSU LARRYDirector 2014-06-06Sell100,000$28.3876.5view
TERRERI PETER RDirector 2014-05-27Sell3,000$2878.89view
HSU LARRYDirector 2014-05-22Sell50,000$27.2284.02view
HSU LARRYDirector 2014-05-21Sell3,800$26.5388.81view
TERRERI PETER RDirector 2014-05-20Sell666$26.0792.14view
TERRERI PETER RDirector 2014-05-19Sell950$26.0392.43view
FLEMING NIGELDirector 2014-05-16Sell1,900$25.7294.75view
TERRERI PETER RDirector 2014-05-13Sell666$26.787.6view
FLEMING NIGELDirector 2014-05-12Sell1,333$26.5888.45view
MARKBREITER MICHAELDirector 2014-05-08Sell12,500$26.4489.45view

Press Releases about IPXL :

    Quarterly/Annual Reports about IPXL:

    News about IPXL:

    Articles On GuruFocus.com
    Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
    comment on IPXL Sep 24 2012 
    President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 
    Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 5,000 Shares Aug 12 2010 
    Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 10,000 Shares Aug 12 2010 
    Impax Laboratories Reports Second Quarter 2009 Financial Results Aug 04 2009 


    More From Other Websites
    Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs Apr 23 2015
    Impax Labs downgraded by UBS Apr 17 2015
    UBS Says Impax 'Ahead Of Itself,' Downgrades To Sell Apr 17 2015
    Tesoro Corporation (TSO), Walgreens Boots Alliance Inc (WBA), and Impax Laboratories Inc (IPXL):... Apr 16 2015
    Impax to Report First Quarter 2015 Results on May 11, 2015 Apr 16 2015
    Impax to Report First Quarter 2015 Results on May 11, 2015 Apr 16 2015
    Impax Laboratories (IPXL) Shares March Higher, Can It Continue? - Tale of the Tape Apr 09 2015
    2 Biotech Stocks Deutsche Bank Just Initiated Apr 08 2015
    Generic Companies Are Fighting for Market Share Mar 28 2015
    What’s Supporting Continued Growth in the Generics Market? Mar 28 2015
    IMPAX LABORATORIES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Mar 25 2015
    Is a Para IV Filing Rewarding for a Generic Company? Mar 25 2015
    Regulations Are Instrumental in the Marketing Authorization Process Mar 25 2015
    Why Is the Generics Industry Controlled by Regulations? Mar 25 2015
    Two Future Leaders of Specialty Pharma Mar 23 2015
    What Two Factors Are Driving the US Generics Market? Mar 23 2015
    Why the Generic Industry’s Classification Is Still Evolving Mar 19 2015
    Are Generics the Only Affordable Drugs? Mar 19 2015
    Actavis Receives FDA Approval for Saphris' Label Expansion - Analyst Blog Mar 16 2015
    ACADIA Down on Nuplazid NDA Delay and CEO Resignation - Analyst Blog Mar 13 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK